Age-related cognitive decline affects memory, processing speed, and executive function. Researchers are investigating neuroprotective peptides such as Semax, Selank, and Dihexa for their potential roles in supporting BDNF expression, synaptic plasticity, and neural connectivity.
Cardiovascular disease encompasses atherosclerosis, heart failure, and vascular dysfunction. Peptides including Thymosin Beta-4, natriuretic peptides, and GLP-1 receptor agonists are being researched for cardioprotective, anti-inflammatory, and regenerative effects, with GLP-1 agonists showing landmark clinical trial results.
Chronic fatigue syndrome (ME/CFS) is increasingly linked to mitochondrial dysfunction and impaired cellular energy production. Mitochondrial-derived peptides such as SS-31 (elamipretide), MOTS-c, and humanin are being investigated for their potential to restore bioenergetic function in affected individuals.
Chronic inflammation drives conditions like rheumatoid arthritis, IBD, and lupus. Researchers are investigating peptides such as BPC-157, Thymosin Beta-4, KPV, and Thymosin Alpha-1 for their potential roles in modulating immune responses and supporting tissue repair.
Intestinal permeability, or leaky gut, involves the breakdown of tight junctions in the gut lining, contributing to IBS, IBD, and systemic inflammation. Peptides including BPC-157, larazotide acetate, and KPV are being investigated for their potential to restore barrier integrity and modulate gut inflammation.
Hormonal imbalances involving growth hormone, sex hormones, and thyroid function affect millions and worsen with age. Peptides such as CJC-1295, ipamorelin, and the FDA-approved PT-141 (bremelanotide) are being researched for their potential to stimulate the body's natural hormone production pathways.
Chronic infections and immune deficiencies leave individuals vulnerable to recurrent and severe illness. Peptides such as Thymosin Alpha-1, LL-37, and defensins are being researched for their potential to restore immune function and provide antimicrobial defense through mechanisms that may circumvent antibiotic resistance.
Metabolic syndrome affects roughly one-third of American adults, driven by insulin resistance, abdominal obesity, and dyslipidemia. GLP-1 receptor agonists like semaglutide and tirzepatide have shown strong clinical evidence, while peptides such as AOD-9604 are being studied in preclinical settings.
Musculoskeletal injuries involving tendons, ligaments, and joints are characterized by limited natural regenerative capacity. Peptides such as BPC-157, TB-500, and collagen peptides are being studied for their potential to enhance tissue repair, reduce fibrotic scarring, and support recovery from osteoarthritis.
Skin aging and photoaging involve the progressive breakdown of collagen and the extracellular matrix, leading to wrinkles, loss of elasticity, and impaired wound healing. Peptides such as GHK-Cu, Matrixyl, and EGF are being researched for their ability to stimulate collagen production, accelerate tissue repair, and rejuvenate aging skin.